Uterus1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 Uterus News
Feature Story
 Education Center

Conditions
Treatments
Diagnostics

Find a Physician
HTA in the News
 Heavy Periods Center
sharonbober  Uterus
 Hero™

Dr. Sharon Bober:
Healing the Sex Lives of Cancer Patients
About Heroes
 Join the Discussion in  Our Forums
 Community
Uterus1 Forums
Patient Stories
Frequently
    Asked Questions

One Question Poll
    Archive

 Reference
Locate a Specialist
Online Resources
Uterus Anatomy
Video Library
Menstrual Diary
Office Visits
Patient Brochures
  
advertisement
Search the Body1 Network
April 29, 2017  
UTERINE NEWS: Feature Story

  • Print this Article
  • Email this Article
  • IUD Device Doubles as Treatment for Heavy Periods

    IUD Device Doubles as Treatment for Heavy Periods


    December 13, 2004

    By: Diana Barnes-Brown

    While many women have already realized the convenience and effectiveness of using intrauterine devices (IUDs) as a birth control method, new research has suggested that a certain type of these birth control devices can double as a treatment for excessively heavy periods, or menorrhagia.

    The specific IUD that was studied, known by the brand name Mirena, was previously approved by the FDA as an safe, reversible form of long-term birth control, and now has been found to have an effect on the duration and intensity of women’s periods.

    Researchers in Finland are responsible for the findings, which are published in the December, 2004 Obstetrics and Gynecology. Dr. Ilkka Rauramo and colleagues at the Finnish Medical Society Duodecim in Helsinki conducted the study.

    The researchers compared the results of endometrial ablation – or surgical removal of the uterine lining – with use of Mirena in a group of 59 women who suffered from disruptively or abnormally heavy menstrual bleeding.

    They compared the 19 out of 30 patients who were treated with Mirena and completed the 3-year follow-up necessary for study participation, and 22 out of 29 patients who had undergone endometrial surgery and completed the follow-up period, and found that in both groups, the amount of bleeding during periods had been drastically reduced.

    The women indicated blood loss by recording use of menstrual products like pads and tampons, as well as looking at pictorial charts to show the amount of perceived soiling.

    While removal of the endometrium, which can be done as a minimally invasive procedure, is a big advance from prior treatments for menorrhagia – which included dilation and curettage (D&C), hormone treatments, and sometimes even hysterectomy – insertion of Mirena is even simpler and less likely to cause negative after effects in eligible candidates.

    The findings, they can be replicated with a larger number of patients and thus become generalizable, will represent a big step in treating menorrhagia. On the basis of our data and the literature, strong evidence exists to suggest [the Mirena IUD] should be considered the first-line treatment,” noted Rauramo’s team. The device “is easy to insert, has a sustained effect, provides contraception, may reduce the need for surgery, and is cost-effective and well tolerated,” they concluded.

    Mirena is a small plastic device containing trace amounts of reproductive hormone levonorgestrel, prevents pregnancy by thinning the lining of the uterus, thickening cervical mucus to provide an additional barrier against sperm, and interfering with the movement of sperm that does enter the uterus.

    Research from Mirena’s maker, Berlex, shows the device to be 99.9 percent dependable if properly inserted. The device’s effects last for five years, and it can be inserted into the uterus by a doctor in just a few minutes. It is important to note, however, that Mirena is not capable of preventing infection with HIV or other STDs, and that barrier methods such as condoms and dental dams are still the only recommended way to practice safer sex.

    Source: Obstetrics and Gynecology, December 2004; http://www.mirena-us.com/

    Last updated: 13-Dec-04

    Comments

  • Add Comment
  •    
    Interact on Uterus1

    Discuss this topic with others.
     
    Feature Archives

    Breast Milk as Nutrition and Medication for Critically Ill Infants

    Study Finds New Moms Still Excessively Sleepy After Four Months

    Preterm Infants and Their Mothers Benefit from Maternal Singing During Skin-to-Skin Contact

    Stress Impacts Ability to Get Pregnant

    Link Discovered Between Bacteria and Premature Water Breaking

    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    Interview with James Spies, M.D. - Fibroids, Symptoms and Benefits of the Solution

    Interview with James Spies, M.D. about Treatments for Fibroids

    The HTA® System for Menorrhagia

    More Features ...
     
    Related Content
    Heavy Bleeding 101

    Heavy Bleeding

    Menorrhagia

    Fibroids Update: Who is At Risk

    Menorrhagia

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2017 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.